Rollema, Hans <br/><br/>
Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition.  [electronic resource] 

 -  Biochemical pharmacology  Oct 2009 
 - 813-24 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2968 
<br/><br/><label>Standard No.: </label>10.1016/j.bcp.2009.05.033  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Affect--drug effects<br/>Alcohol Drinking--drug therapy<br/>Animals<br/>Attention--drug effects<br/>Benzazepines--pharmacology<br/>Cerebral Cortex--drug effects<br/>Cognition--drug effects<br/>Depression--drug therapy<br/>Drug Partial Agonism<br/>Hippocampus--drug effects<br/>Humans<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Neurotransmitter Agents--metabolism<br/>Nicotinic Agonists--pharmacology<br/>Quinoxalines--pharmacology<br/>Rats<br/>Rats, Sprague-Dawley<br/>Rats, Wistar<br/>Receptors, Nicotinic--physiology<br/>Recognition, Psychology--drug effects<br/>Reflex, Startle--drug effects<br/>Reward<br/>Tobacco Use Disorder--drug therapy<br/>Varenicline